BioWorld

@BioWorld

Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Anette Breindl, Michael Fitzhugh, Lee Landenberger, Randy Osborne, Mari Serebrov, Peter Winter

USA
Vrijeme pridruživanja: travanj 2009.

Tweetovi

Blokirali ste korisnika/cu @BioWorld

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioWorld

  1. prije 13 sati
    Poništi
  2. prije 14 sati
    Poništi
  3. prije 14 sati
    Poništi
  4. prije 14 sati
    Poništi
  5. prije 14 sati
    Poništi
  6. prije 14 sati
    Poništi
  7. prije 14 sati
    Poništi
  8. prije 18 sati

    South Korean biotech Novelty Nobility has attracted ₩10 billion (US$9 million) in series A funding to develop therapeutic antibodies inhibiting the stem cell factor (SCF)/c-KIT pathway.

    Poništi
  9. prije 22 sata

    Now that HHS Secretary Alex Azar () has declared a nationwide public health emergency due to the 2019 novel , is saying it may need more $$$ to help it be as proactive and aggressive as possible

    Poništi
  10. prije 22 sata

    Investors in small and midsized biopharma companies were certainly rewarded in 2019, with group members in the BioWorld Drug Developers index on a tear.

    Poništi
  11. prije 22 sata

    Don't forget: continues to offer free access to all our news stories here:

    Poništi
  12. prije 22 sata

    At this very early point in the emerging , knowledge about the virus is insufficient to predict what shape that outbreak will ultimately take.

    Poništi
  13. 4. velj
    Poništi
  14. 4. velj
    Poništi
  15. 4. velj

    Coronavirus: Chinese researchers claim TCM herbal remedy could ‘inhibit’ 2019-nCoV

    Poništi
  16. 4. velj

    Preventing a U.S. outbreak: Emergency declaration leads to hunt for more funding

    Poništi
  17. 4. velj
    Poništi
  18. 4. velj

    The National Institute of Allergy and Infectious Diseases has stopped a late-stage HIV vaccine study it sponsored after an interim review by the trial's independent data and safety monitoring board found the regimen failed to prevent HIV.

    Poništi
  19. 4. velj

    . has declared a public health emergency in the U.S. over the in part because a government diagnostic for the virus yields inconsistent results, a fact that may spur the life sciences to provide a solution.

    Poništi
  20. 4. velj

    Biotech investors had every reason to feel bullish heading into the new decade. Unfortunately, those great expectations were quickly erased during J.P. Morgan Healthcare conference week.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·